taurine has been researched along with Stroke in 19 studies
Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Taurine promoted axonal sprouting via Shh-mediated mitochondrial improvement in ischemic stroke." | 8.31 | Taurine promotes axonal sprouting via Shh-mediated mitochondrial improvement in stroke. ( He, J; He, W; Jia, J; Ma, G; Tian, X, 2023) |
| "Taurine (2-aminoethansulfolic amino acid) exerts neuroprotective actions in experimental stroke." | 7.88 | Taurine Reduces tPA (Tissue-Type Plasminogen Activator)-Induced Hemorrhage and Microvascular Thrombosis After Embolic Stroke in Rat. ( Jin, R; Li, G; Liu, S; Wang, M; Xiao, AY, 2018) |
| " Taurine was measured in pre-diagnostic serum samples of 241 stroke cases and 479 matched controls." | 7.83 | Serum Taurine and Stroke Risk in Women: A Prospective, Nested Case-Control Study. ( Afanasyeva, Y; Chen, Y; Costa, M; Jonas, S; Koenig, KL; Wójcik, OP; Wu, F; Zeleniuch-Jacquotte, A, 2016) |
| "Taurine is reported to reduce tissue damage induced by inflammation and to protect the brain against experimental stroke." | 7.78 | Anti-inflammatory mechanism of taurine against ischemic stroke is related to down-regulation of PARP and NF-κB. ( Gu, Y; Sun, M; Xu, C; Zhao, Y, 2012) |
| "The dose-dependent protection of taurine against experimental stroke has been demonstrated previously." | 7.78 | Therapeutic window of taurine against experimental stroke in rats. ( Gu, Y; Sun, M; Xu, C; Zhao, YM, 2012) |
| "Post-transcriptional taurine modification at the first anticodon ("wobble") nucleotide is deficient in A3243G-mutant mitochondrial (mt) tRNA(Leu(UUR)) of patients with myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS)." | 7.78 | Taurine ameliorates impaired the mitochondrial function and prevents stroke-like episodes in patients with MELAS. ( Ichimiya, H; Kamimura, N; Nishimaki, K; Nishimatsu, S; Ohsawa, Y; Ohta, S; Rikimaru, M; Sunada, Y; Wolf, AM, 2012) |
| "Taurine is an inhibitory neurotransmitter and is one of the most abundant amino acids present in the mammalian nervous system." | 5.39 | The mechanism of taurine protection against endoplasmic reticulum stress in an animal stroke model of cerebral artery occlusion and stroke-related conditions in primary neuronal cell culture. ( Chen, PC; Gharibani, PM; Ma, Z; Menzie, J; Modi, J; Pan, C; Prentice, H; Tao, R; Wu, JY, 2013) |
| "Taurine (T) was first noted as beneficial for stroke and cardiovascular diseases (CVD) prevention in genetic rat models, stroke-prone spontaneously hypertensive rats (SHRSP)." | 4.86 | Taurine in health and diseases: consistent evidence from experimental and epidemiological studies. ( Hamada, A; Kunimasa, K; Mori, H; Mori, M; Taguchi, T; Yamori, Y, 2010) |
| "In MELAS, taurine modification defect in the anticodon of mitochondrial leucine tRNA causes codon translation failure." | 4.31 | [Therapeutics for Mitochondrial Encephalomyopathy]. ( Sunada, Y, 2023) |
| "Taurine promoted axonal sprouting via Shh-mediated mitochondrial improvement in ischemic stroke." | 4.31 | Taurine promotes axonal sprouting via Shh-mediated mitochondrial improvement in stroke. ( He, J; He, W; Jia, J; Ma, G; Tian, X, 2023) |
| "To investigate the association of the Japanese diet with risks for lifestyle-related diseases, the biomarkers of seafood and soybean consumption, taurine (T) and soy isoflavones (I), and others were analyzed in 24-hour urine (24U) samples collected from participants of the Cardiovascular Diseases and Alimentary Comparison (CARDIAC) Study coordinated by the World Health Organization (WHO)." | 4.12 | Grading of Japanese Diet Intakes by 24-Hour Urine Analysis of Taurine and Soy Isoflavones in Relation to Cardiovascular Risks. ( Mori, H; Mori, M; Sagara, M; Yamori, Y, 2022) |
| "Taurine (2-aminoethansulfolic amino acid) exerts neuroprotective actions in experimental stroke." | 3.88 | Taurine Reduces tPA (Tissue-Type Plasminogen Activator)-Induced Hemorrhage and Microvascular Thrombosis After Embolic Stroke in Rat. ( Jin, R; Li, G; Liu, S; Wang, M; Xiao, AY, 2018) |
| "Emerging evidence has suggested that hydrogen sulfide (H2S) may alleviate the cellular damage associated with cerebral ischemia/reperfusion (I/R) injury." | 3.85 | The administration of hydrogen sulphide prior to ischemic reperfusion has neuroprotective effects in an acute stroke model. ( Choi, CG; Choi, Y; Ha, HK; Ham, SJ; Jeon, SB; Jung, SC; Kim, J; Kim, JK; Kim, KW; Kim, ST; Kwon, JI; Shim, WH; Sung, YS; Woo, CW; Woo, DC, 2017) |
| " Taurine was measured in pre-diagnostic serum samples of 241 stroke cases and 479 matched controls." | 3.83 | Serum Taurine and Stroke Risk in Women: A Prospective, Nested Case-Control Study. ( Afanasyeva, Y; Chen, Y; Costa, M; Jonas, S; Koenig, KL; Wójcik, OP; Wu, F; Zeleniuch-Jacquotte, A, 2016) |
| "Taurine is reported to reduce tissue damage induced by inflammation and to protect the brain against experimental stroke." | 3.78 | Anti-inflammatory mechanism of taurine against ischemic stroke is related to down-regulation of PARP and NF-κB. ( Gu, Y; Sun, M; Xu, C; Zhao, Y, 2012) |
| "The dose-dependent protection of taurine against experimental stroke has been demonstrated previously." | 3.78 | Therapeutic window of taurine against experimental stroke in rats. ( Gu, Y; Sun, M; Xu, C; Zhao, YM, 2012) |
| "Post-transcriptional taurine modification at the first anticodon ("wobble") nucleotide is deficient in A3243G-mutant mitochondrial (mt) tRNA(Leu(UUR)) of patients with myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS)." | 3.78 | Taurine ameliorates impaired the mitochondrial function and prevents stroke-like episodes in patients with MELAS. ( Ichimiya, H; Kamimura, N; Nishimaki, K; Nishimatsu, S; Ohsawa, Y; Ohta, S; Rikimaru, M; Sunada, Y; Wolf, AM, 2012) |
| " Stroke mortality was associated positively with Na and Na/K ratio and phospholipid arachidonic acid (AA), and negatively with TC and K." | 3.73 | Male cardiovascular mortality and dietary markers in 25 population samples of 16 countries. ( Ikeda, K; Liu, L; Mizushima, S; Nara, Y; Yamori, Y, 2006) |
| "Taurine is an inhibitory neurotransmitter and is one of the most abundant amino acids present in the mammalian nervous system." | 1.39 | The mechanism of taurine protection against endoplasmic reticulum stress in an animal stroke model of cerebral artery occlusion and stroke-related conditions in primary neuronal cell culture. ( Chen, PC; Gharibani, PM; Ma, Z; Menzie, J; Modi, J; Pan, C; Prentice, H; Tao, R; Wu, JY, 2013) |
| "We introduced intracerebral hemorrhage in each of eight anesthetized New Zealand rabbits by injecting 0." | 1.32 | Extracellular glutamate and other amino acids in experimental intracerebral hemorrhage: an in vivo microdialysis study. ( Ali, Z; Baker, G; Guterman, LR; Hopkins, LN; Qureshi, AI; Shuaib, A; Suri, MF; Todd, K, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 14 (73.68) | 24.3611 |
| 2020's | 3 (15.79) | 2.80 |
| Authors | Studies |
|---|---|
| Mori, M | 2 |
| Sagara, M | 1 |
| Mori, H | 2 |
| Yamori, Y | 3 |
| Sunada, Y | 3 |
| Jia, J | 1 |
| Tian, X | 1 |
| He, J | 1 |
| Ma, G | 1 |
| He, W | 1 |
| Woo, CW | 1 |
| Kwon, JI | 1 |
| Kim, KW | 1 |
| Kim, JK | 1 |
| Jeon, SB | 1 |
| Jung, SC | 1 |
| Choi, CG | 1 |
| Kim, ST | 1 |
| Kim, J | 1 |
| Ham, SJ | 1 |
| Shim, WH | 1 |
| Sung, YS | 1 |
| Ha, HK | 1 |
| Choi, Y | 1 |
| Woo, DC | 1 |
| Ohsawa, Y | 2 |
| Hagiwara, H | 1 |
| Nishimatsu, SI | 1 |
| Hirakawa, A | 1 |
| Kamimura, N | 2 |
| Ohtsubo, H | 1 |
| Fukai, Y | 1 |
| Murakami, T | 1 |
| Koga, Y | 1 |
| Goto, YI | 1 |
| Ohta, S | 2 |
| Jin, R | 1 |
| Xiao, AY | 1 |
| Liu, S | 1 |
| Wang, M | 1 |
| Li, G | 1 |
| Windpessl, M | 1 |
| Müller, P | 1 |
| Wu, S | 1 |
| Yue, Y | 1 |
| Tian, H | 1 |
| Tao, L | 1 |
| Wang, Y | 1 |
| Xiang, J | 1 |
| Wang, S | 1 |
| Ding, H | 1 |
| Wu, F | 1 |
| Koenig, KL | 1 |
| Zeleniuch-Jacquotte, A | 1 |
| Jonas, S | 1 |
| Afanasyeva, Y | 1 |
| Wójcik, OP | 1 |
| Costa, M | 1 |
| Chen, Y | 1 |
| Taguchi, T | 1 |
| Hamada, A | 1 |
| Kunimasa, K | 1 |
| Sun, M | 3 |
| Gu, Y | 3 |
| Zhao, Y | 2 |
| Xu, C | 3 |
| Ghandforoush-Sattari, M | 1 |
| Mashayekhi, SO | 1 |
| Nemati, M | 1 |
| Ayromlou, H | 1 |
| Zhao, YM | 1 |
| Tu, J | 1 |
| A, J | 1 |
| Wang, G | 1 |
| Wen, H | 1 |
| Wang, A | 1 |
| Di, L | 1 |
| Cao, B | 1 |
| Liu, L | 2 |
| Rikimaru, M | 1 |
| Wolf, AM | 1 |
| Nishimaki, K | 1 |
| Ichimiya, H | 1 |
| Nishimatsu, S | 1 |
| Gharibani, PM | 1 |
| Modi, J | 1 |
| Pan, C | 1 |
| Menzie, J | 1 |
| Ma, Z | 1 |
| Chen, PC | 1 |
| Tao, R | 1 |
| Prentice, H | 1 |
| Wu, JY | 1 |
| Qureshi, AI | 1 |
| Ali, Z | 1 |
| Suri, MF | 1 |
| Shuaib, A | 1 |
| Baker, G | 1 |
| Todd, K | 1 |
| Guterman, LR | 1 |
| Hopkins, LN | 1 |
| Mizushima, S | 1 |
| Ikeda, K | 1 |
| Nara, Y | 1 |
1 review available for taurine and Stroke
| Article | Year |
|---|---|
Taurine in health and diseases: consistent evidence from experimental and epidemiological studies.
Topics: Animals; Blood Pressure; Cardiovascular Diseases; Cholesterol, Dietary; Diet; Dietary Fats; Humans; | 2010 |
1 trial available for taurine and Stroke
| Article | Year |
|---|---|
Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial.
Topics: Administration, Oral; Adolescent; Adult; Dietary Supplements; Female; Humans; Male; MELAS Syndrome; | 2019 |
17 other studies available for taurine and Stroke
| Article | Year |
|---|---|
Grading of Japanese Diet Intakes by 24-Hour Urine Analysis of Taurine and Soy Isoflavones in Relation to Cardiovascular Risks.
Topics: Cardiovascular Diseases; Diet; Heart Disease Risk Factors; Humans; Isoflavones; Japan; Risk Factors; | 2022 |
[Therapeutics for Mitochondrial Encephalomyopathy].
Topics: Arginine; Humans; MELAS Syndrome; Mitochondria; Stroke; Taurine | 2023 |
Taurine promotes axonal sprouting via Shh-mediated mitochondrial improvement in stroke.
Topics: Adenosine Triphosphate; Animals; DNA, Mitochondrial; Hedgehog Proteins; Ischemic Stroke; Mice; Mitoc | 2023 |
The administration of hydrogen sulphide prior to ischemic reperfusion has neuroprotective effects in an acute stroke model.
Topics: Animals; Apoptosis; Aspartic Acid; Brain Ischemia; Disease Models, Animal; Glutamic Acid; Humans; Hy | 2017 |
Taurine Reduces tPA (Tissue-Type Plasminogen Activator)-Induced Hemorrhage and Microvascular Thrombosis After Embolic Stroke in Rat.
Topics: Animals; Disease Models, Animal; Fibrinolytic Agents; Infarction, Middle Cerebral Artery; Intracrani | 2018 |
Valproic acid and MELAS: a word of warning.
Topics: Female; Humans; MELAS Syndrome; Mitochondria; Stroke; Taurine | 2013 |
Tramiprosate protects neurons against ischemic stroke by disrupting the interaction between PSD95 and nNOS.
Topics: Animals; Apoptosis; Brain Ischemia; Disks Large Homolog 4 Protein; Intracellular Signaling Peptides | 2014 |
Serum Taurine and Stroke Risk in Women: A Prospective, Nested Case-Control Study.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antioxidants; Bile Acids and Salts; Blood Pressure; Case-Cont | 2016 |
Protective functions of taurine against experimental stroke through depressing mitochondria-mediated cell death in rats.
Topics: Adenosine Triphosphate; Animals; bcl-2-Associated X Protein; bcl-X Protein; Brain Ischemia; Calpain; | 2011 |
Anti-inflammatory mechanism of taurine against ischemic stroke is related to down-regulation of PARP and NF-κB.
Topics: Animals; Anti-Inflammatory Agents; Brain; Cell Death; Disease Models, Animal; Gene Expression Regula | 2012 |
Changes in plasma concentration of taurine in stroke.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Biomarkers; Blood Pressure; Chromatography, High Pres | 2011 |
Therapeutic window of taurine against experimental stroke in rats.
Topics: Animals; Male; Rats; Rats, Sprague-Dawley; Stroke; Taurine | 2012 |
[Plasma metabonomics study of ischemic cerebral apoplexy rats treated with Tongsaimai pellets].
Topics: Animals; Brain Ischemia; Drugs, Chinese Herbal; Fructose; Glyceric Acids; Hydroxyproline; Lactic Aci | 2012 |
Taurine ameliorates impaired the mitochondrial function and prevents stroke-like episodes in patients with MELAS.
Topics: Adult; Cells, Cultured; Female; Humans; MELAS Syndrome; Mitochondria; Stroke; Taurine; Young Adult | 2012 |
The mechanism of taurine protection against endoplasmic reticulum stress in an animal stroke model of cerebral artery occlusion and stroke-related conditions in primary neuronal cell culture.
Topics: Activating Transcription Factor 6; Animals; Apoptosis; Brain Ischemia; Caspase 12; Caspase 3; Cell S | 2013 |
Extracellular glutamate and other amino acids in experimental intracerebral hemorrhage: an in vivo microdialysis study.
Topics: Analysis of Variance; Animals; Asparagine; Aspartic Acid; Brain Ischemia; Cerebral Hemorrhage; Chrom | 2003 |
Male cardiovascular mortality and dietary markers in 25 population samples of 16 countries.
Topics: Age Factors; Aged; Americas; Analysis of Variance; Arachidonic Acid; Asia; Australia; Biomarkers; Ch | 2006 |